168 related articles for article (PubMed ID: 34849004)
1. SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma.
Feng D; Zhang F; Liu L; Xiong Q; Xu H; Wei W; Liu Z; Yang L
Int J Gen Med; 2021; 14():8591-8602. PubMed ID: 34849004
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.
Tang J; Liu J; Li J; Liang Z; Zeng K; Li H; Zhao Z; Zhou L; Jiang N
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760206
[TBL] [Abstract][Full Text] [Related]
4. SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma.
Chen C; Guo Q; Song Y; Xu G; Liu L
Transl Lung Cancer Res; 2020 Apr; 9(2):218-231. PubMed ID: 32420061
[TBL] [Abstract][Full Text] [Related]
5. High PAQR4 mRNA Expression May Play a Key Role in Prognosis of Kidney Renal Papillary Cell Carcinoma.
Liu C; Cai W; Tang P; Li C
Ann Clin Lab Sci; 2023 Sep; 53(5):701-711. PubMed ID: 37945022
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of
Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
[No Abstract] [Full Text] [Related]
7. Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target.
Gong X; Gong Y; Wu G; Ke H
Medicine (Baltimore); 2024 Mar; 103(12):e37609. PubMed ID: 38518000
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CDCA3 in kidney renal papillary cell carcinoma.
Li H; Li M; Yang C; Guo F; Deng S; Li L; Ma T; Yan J; Wu H; Li X
Aging (Albany NY); 2021 Dec; 13(23):25466-25483. PubMed ID: 34905505
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer.
Zhong Y; Zhuang Z; Mo P; Lin M; Gong J; Huang J; Mo H; Lu Y; Huang M
PeerJ; 2021; 9():e12506. PubMed ID: 34993016
[TBL] [Abstract][Full Text] [Related]
10. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.
Gao W; Zhang Y; Luo H; Niu M; Zheng X; Hu W; Cui J; Xue X; Bo Y; Dai F; Lu Y; Yang D; Guo Y; Guo H; Li H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Ma T; Jin L; Xu W; Wu Y
Cell Death Dis; 2020 Oct; 11(10):919. PubMed ID: 33106477
[TBL] [Abstract][Full Text] [Related]
11. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
12. Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration.
Gan L; Xiao Q; Zhou Y; Fu Y; Tang M
Front Pharmacol; 2023; 14():1211675. PubMed ID: 37456749
[No Abstract] [Full Text] [Related]
13. High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
Zheng LL; Wang YR; Liu ZR; Wang ZH; Tao CC; Xiao YG; Zhang K; Wu AK; Li HY; Wu JX; Xiao T; Rong WQ
World J Gastrointest Surg; 2023 Aug; 15(8):1600-1614. PubMed ID: 37701707
[TBL] [Abstract][Full Text] [Related]
14. Spindle and kinetochore-associated complex subunit 3 could serve as a prognostic biomarker for prostate cancer.
Feng D; Zhu W; Shi X; Xiong Q; Li D; Wei W; Han P; Wei Q; Yang L
Exp Hematol Oncol; 2022 Oct; 11(1):76. PubMed ID: 36266657
[TBL] [Abstract][Full Text] [Related]
15. SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma.
Song GQ; He TL; Ji KJ; Duan YM; Zhang JW; Hu GQ
Front Oncol; 2022; 12():1038925. PubMed ID: 36439516
[TBL] [Abstract][Full Text] [Related]
16. miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition.
Wu Y; Dai F; Zhang Y; Zheng X; Li L; Zhang Y; Cao J; Gao W
Mol Ther Oncolytics; 2021 Sep; 22():152-165. PubMed ID: 34514096
[TBL] [Abstract][Full Text] [Related]
17. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
18. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
19. SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway.
Hu R; Wang MQ; Niu WB; Wang YJ; Liu YY; Liu LY; Wang M; Zhong J; You HY; Wu XH; Deng N; Lu L; Wei LB
Cancer Cell Int; 2018; 18():183. PubMed ID: 30459531
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas.
Yu S
Front Neurol; 2021; 12():755681. PubMed ID: 35095717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
